stockmarketproxy
/
HCANYSE SEC EDGAR

HCA Healthcare, Inc.

Services-General Medical & Surgical Hospitals, NEC·NASHVILLE, TN·FY end 12/31·CIK 860730
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$75.6B$70.6B$65.0B$60.2B$58.8B
Gross Profit——————
Operating Income——————
Net Income$6.8B$5.8B$5.2B$5.6B$7.0B
Operating CF$12.6B$10.5B$9.4B$8.5B$9.0B
Capex$4.9B$4.9B$4.7B$4.4B$3.6B
Free Cash Flow$7.7B$5.6B$4.7B$4.1B$5.4B
Buybacks$10.1B$6.0B$3.8B$7.0B$8.2B
Dividends——————
Gross Margin——————
Operating Margin——————
Net Margin9.0%8.2%8.1%9.4%11.8%
FCF Margin10.2%8.0%7.2%6.9%9.2%
R&D / Revenue——————
Effective Tax20.9%21.9%21.0%20.3%21.5%
Debt / Equity-14.25-32.56-43.27-27.39-73.87
Buybacks / FCF130.9%107.1%81.3%169.6%152.6%

Peer comparison

Services-General Medical & Surgical Hospitals, NEC · 2 peers
CEO Pay Ratio
HCA
420:1
THC
—
UHS
283:1
CEO total comp
HCA
—
THC
$43M
UHS
$16M
Net Margin
HCA
9.0%
THC
—
UHS
8.6%